Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Genetic insights into the risk of metabolic syndrome and its components on psoriasis: A bidirectional Mendelian randomization

Submitted by Frida Mäkelä on Wed, 08/02/2023 - 14:58
  • Read more about Genetic insights into the risk of metabolic syndrome and its components on psoriasis: A bidirectional Mendelian randomization

Potential causal evidence for an ApoB-independent and HDL-related risk profile associated with coronary artery disease

Submitted by Frida Mäkelä on Wed, 08/02/2023 - 13:59
  • Read more about Potential causal evidence for an ApoB-independent and HDL-related risk profile associated with coronary artery disease

Leveraging type 1 diabetes human genetic and genomic data in the T1D Knowledge Portal

Submitted by Frida Mäkelä on Wed, 08/02/2023 - 13:58
  • Read more about Leveraging type 1 diabetes human genetic and genomic data in the T1D Knowledge Portal

Body mass index and risk of inflammatory breast disease: a Mendelian randomization study

Submitted by Frida Mäkelä on Tue, 08/01/2023 - 09:02
  • Read more about Body mass index and risk of inflammatory breast disease: a Mendelian randomization study

Causal Effects of Plasma Haptoglobin Levels on Alzheimer's Disease: A Two-Sample Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 07/31/2023 - 14:42
  • Read more about Causal Effects of Plasma Haptoglobin Levels on Alzheimer's Disease: A Two-Sample Mendelian Randomization Study

The shared ancestry between the C9orf72 hexanucleotide repeat expansion and intermediate-length alleles using haplotype sharing trees and HAPTK

Submitted by Frida Mäkelä on Mon, 07/31/2023 - 10:16
  • Read more about The shared ancestry between the C9orf72 hexanucleotide repeat expansion and intermediate-length alleles using haplotype sharing trees and HAPTK

Genetic variation in SLC5A2 mimicking SGLT2-inhibition and risk of cardiovascular disease and all-cause mortality: reduced risk not explained by lower plasma glucose

Submitted by Frida Mäkelä on Mon, 07/31/2023 - 09:55
  • Read more about Genetic variation in SLC5A2 mimicking SGLT2-inhibition and risk of cardiovascular disease and all-cause mortality: reduced risk not explained by lower plasma glucose

Association between the use of lipid-lowering drugs and the risk of inflammatory bowel disease

Submitted by Frida Mäkelä on Mon, 07/31/2023 - 09:45
  • Read more about Association between the use of lipid-lowering drugs and the risk of inflammatory bowel disease

The Association between Circulating Lipids and Female Infertility Risk: A Univariable and Multivariable Mendelian Randomization Analysis

Submitted by Frida Mäkelä on Mon, 07/31/2023 - 09:39
  • Read more about The Association between Circulating Lipids and Female Infertility Risk: A Univariable and Multivariable Mendelian Randomization Analysis

Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study

Submitted by Frida Mäkelä on Mon, 07/31/2023 - 09:37
  • Read more about Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 333
  • Page 334
  • Page 335
  • Page 336
  • Current page 337
  • Page 338
  • Page 339
  • Page 340
  • Page 341
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement